Comments
FDA staff unsure about new use for Amgen's Xgeva
07.02.2012. | WASHINGTON (Reuters) - Reviewers from Food and Drug Administration said they were not sure whether Amgen Inc's Xgeva bone drug should be also approved as a treatment to delay the spread of cancer to the bone....
